1.
Takasaki S, Kawasaki Y, Kikuchi M, Ito A, Yamaguchi H, Mano N. Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma. J Pharm Pharm Sci [Internet]. 2021 Mar. 16 [cited 2025 Nov. 20];24:127-36. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31816